ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology

J. Arends; G. Bodoky; F. Bozzetti; K.C. Fearon; M. Muscaritoli; G. Selga; M.A. van Bokhorst- de van der Schueren; M.F. von Meyenfeldt; G. Zurcher; R. Fietkau; E. Aulbert; B. Frick; M. Holm; M. Kneba; H.J. Mestrom; A. Zander

doi:10.1016/j.clnu.2006.01.020

ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology

J. Arends^*, G. Bodoky, F. Bozzetti, K.C. Fearon, M. Muscaritoli, G. Selga, M.A. van Bokhorst- de van der Schueren, M.F. von Meyenfeldt, G. Zurcher, R. Fietkau, E. Aulbert, B. Frick, M. Holm, M. Kneba, H.J. Mestrom, A. Zander

^*Corresponding author for this work

NUTRIM School of Nutrition and Translational Research in Metabolism

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Enteral nutrition (EN) by means of oral nutritional supplements (ONS) and tube feeding (TF) offers the possibility of increasing or ensuring nutrient intake in cases where normal food intake is inadequate. These guidelines are intended to give evidence-based recommendations for the use of ONS and TF in cancer patients. They were developed by an interdisciplinary expert group in accordance with officially accepted standards, are based on all relevant publications since 1985 and were discussed and accepted in a consensus conference. Undernutrition and cachexia occur frequently in cancer patients and are indicators of poor prognosis. EN should be started if undernutrition already exists or if food intake is markedly reduced for more than 7-10 days. Standard formulae are recommended for EN. Nutritional needs generally are comparable to non-cancer subjects. In cachectic patients metabolic modulators such as progestins, steroids and possibly eicosapentaenoic acid may help to improve nutritional status. EN is indicated preoperatively for 5-7 days in cancer patients undergoing major abdominal surgery. During radiotherapy of head/neck and gastrointestinal regions dietary counselling and ONS prevent weight loss and interruption of radiotherapy. Routine EN is not indicated during (high-dose) chemotherapy.

Original language	English
Pages (from-to)	245-259
Journal	Clinical Nutrition
Volume	25
Issue number	2
DOIs	https://doi.org/10.1016/j.clnu.2006.01.020
Publication status	Published - 1 Jan 2006

Access to Document

10.1016/j.clnu.2006.01.020

Cite this

Arends, J., Bodoky, G., Bozzetti, F., Fearon, K. C., Muscaritoli, M., Selga, G., van Bokhorst- de van der Schueren, M. A., von Meyenfeldt, M. F., Zurcher, G., Fietkau, R., Aulbert, E., Frick, B., Holm, M., Kneba, M., Mestrom, H. J., & Zander, A. (2006). ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology. Clinical Nutrition, 25(2), 245-259. https://doi.org/10.1016/j.clnu.2006.01.020

@article{ef9d7f4e99a24a59994b8a5813609623,

title = "ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology",

abstract = "Enteral nutrition (EN) by means of oral nutritional supplements (ONS) and tube feeding (TF) offers the possibility of increasing or ensuring nutrient intake in cases where normal food intake is inadequate. These guidelines are intended to give evidence-based recommendations for the use of ONS and TF in cancer patients. They were developed by an interdisciplinary expert group in accordance with officially accepted standards, are based on all relevant publications since 1985 and were discussed and accepted in a consensus conference. Undernutrition and cachexia occur frequently in cancer patients and are indicators of poor prognosis. EN should be started if undernutrition already exists or if food intake is markedly reduced for more than 7-10 days. Standard formulae are recommended for EN. Nutritional needs generally are comparable to non-cancer subjects. In cachectic patients metabolic modulators such as progestins, steroids and possibly eicosapentaenoic acid may help to improve nutritional status. EN is indicated preoperatively for 5-7 days in cancer patients undergoing major abdominal surgery. During radiotherapy of head/neck and gastrointestinal regions dietary counselling and ONS prevent weight loss and interruption of radiotherapy. Routine EN is not indicated during (high-dose) chemotherapy.",

author = "J. Arends and G. Bodoky and F. Bozzetti and K.C. Fearon and M. Muscaritoli and G. Selga and {van Bokhorst- de van der Schueren}, M.A. and {von Meyenfeldt}, M.F. and G. Zurcher and R. Fietkau and E. Aulbert and B. Frick and M. Holm and M. Kneba and H.J. Mestrom and A. Zander",

year = "2006",

month = jan,

day = "1",

doi = "10.1016/j.clnu.2006.01.020",

language = "English",

volume = "25",

pages = "245--259",

journal = "Clinical Nutrition",

issn = "0261-5614",

publisher = "Churchill Livingstone",

number = "2",

}

Arends, J, Bodoky, G, Bozzetti, F, Fearon, KC, Muscaritoli, M, Selga, G, van Bokhorst- de van der Schueren, MA, von Meyenfeldt, MF, Zurcher, G, Fietkau, R, Aulbert, E, Frick, B, Holm, M, Kneba, M, Mestrom, HJ & Zander, A 2006, 'ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology', Clinical Nutrition, vol. 25, no. 2, pp. 245-259. https://doi.org/10.1016/j.clnu.2006.01.020

TY - JOUR

T1 - ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology

AU - Arends, J.

AU - Bodoky, G.

AU - Bozzetti, F.

AU - Fearon, K.C.

AU - Muscaritoli, M.

AU - Selga, G.

AU - van Bokhorst- de van der Schueren, M.A.

AU - von Meyenfeldt, M.F.

AU - Zurcher, G.

AU - Fietkau, R.

AU - Aulbert, E.

AU - Frick, B.

AU - Holm, M.

AU - Kneba, M.

AU - Mestrom, H.J.

AU - Zander, A.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Enteral nutrition (EN) by means of oral nutritional supplements (ONS) and tube feeding (TF) offers the possibility of increasing or ensuring nutrient intake in cases where normal food intake is inadequate. These guidelines are intended to give evidence-based recommendations for the use of ONS and TF in cancer patients. They were developed by an interdisciplinary expert group in accordance with officially accepted standards, are based on all relevant publications since 1985 and were discussed and accepted in a consensus conference. Undernutrition and cachexia occur frequently in cancer patients and are indicators of poor prognosis. EN should be started if undernutrition already exists or if food intake is markedly reduced for more than 7-10 days. Standard formulae are recommended for EN. Nutritional needs generally are comparable to non-cancer subjects. In cachectic patients metabolic modulators such as progestins, steroids and possibly eicosapentaenoic acid may help to improve nutritional status. EN is indicated preoperatively for 5-7 days in cancer patients undergoing major abdominal surgery. During radiotherapy of head/neck and gastrointestinal regions dietary counselling and ONS prevent weight loss and interruption of radiotherapy. Routine EN is not indicated during (high-dose) chemotherapy.

AB - Enteral nutrition (EN) by means of oral nutritional supplements (ONS) and tube feeding (TF) offers the possibility of increasing or ensuring nutrient intake in cases where normal food intake is inadequate. These guidelines are intended to give evidence-based recommendations for the use of ONS and TF in cancer patients. They were developed by an interdisciplinary expert group in accordance with officially accepted standards, are based on all relevant publications since 1985 and were discussed and accepted in a consensus conference. Undernutrition and cachexia occur frequently in cancer patients and are indicators of poor prognosis. EN should be started if undernutrition already exists or if food intake is markedly reduced for more than 7-10 days. Standard formulae are recommended for EN. Nutritional needs generally are comparable to non-cancer subjects. In cachectic patients metabolic modulators such as progestins, steroids and possibly eicosapentaenoic acid may help to improve nutritional status. EN is indicated preoperatively for 5-7 days in cancer patients undergoing major abdominal surgery. During radiotherapy of head/neck and gastrointestinal regions dietary counselling and ONS prevent weight loss and interruption of radiotherapy. Routine EN is not indicated during (high-dose) chemotherapy.

U2 - 10.1016/j.clnu.2006.01.020

DO - 10.1016/j.clnu.2006.01.020

M3 - Article

SN - 0261-5614

VL - 25

SP - 245

EP - 259

JO - Clinical Nutrition

JF - Clinical Nutrition

IS - 2

ER -

ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology

Abstract

Access to Document

Fingerprint

Cite this